91.3  0.45 (0.5%)		06-16 16:00
Open: 91.78 High: 91.78 Volume: 160,966		Pre. Close: 90.85 Low: 90.28 Market Cap: 3,100(M)

Short term
Mid term
Targets	6-month :	110.67	1-year :	129.27
Resists	First :	94.76	Second :	110.67
Pivot price	91.13
Supports	First :	88.28	Second :	84.27
MAs	MA(5) :	91.31	MA(20) :	90.92
	MA(100) :	87.09	MA(250) :	91.6
MACD	MACD :	0.9	Signal :	1.1
%K %D	K(14,3) :	46.9	D(3) :	50.2
RSI	RSI(14): 53.8
52-week	High :	123.77	Low :	62

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ITGR ] has closed below upper band by 46.8%. Bollinger Bands are 7.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	91.91 - 92.43	92.43 - 92.9
Low:	88.91 - 89.59	89.59 - 90.21
Close:	90.32 - 91.3	91.3 - 92.2

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Tue, 16 Jun 2026
ITGR: Strategic review underway; growth delayed to late 2026 amid EP market shifts and disciplined cost control - TradingView

Tue, 16 Jun 2026
ITGR: Strategic review underway; growth to resume in late 2026 amid disciplined cost management - TradingView

Tue, 16 Jun 2026
Avoiding Lag: Real-Time Signals in (ITGR) Movement - Stock Traders Daily

Sun, 14 Jun 2026
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integer Holdings Corporation (ITGR) And Encourages Shareholders to Reach Out - ACCESS Newswire

Sat, 06 Jun 2026
A Look At Integer Holdings (ITGR) Valuation After Analyst Optimism And Upcoming MedTech Conference Interest - Sahm

Sat, 06 Jun 2026
Assessing Integer Holdings (ITGR) Valuation After Recent Share Price Momentum - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	34 (M)
Shares Float	34 (M)
Held by Insiders	1.3 (%)
Held by Institutions	118.5 (%)
Shares Short	4,580 (K)
Shares Short P.Month	4,040 (K)

EPS	4.03
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	49.99
Profit Margin	7.6 %
Operating Margin	8.1 %
Return on Assets (ttm)	4.2 %
Return on Equity (ttm)	8.5 %
Qtrly Rev. Growth	0.5 %
Gross Profit (p.s.)	14.65
Sales Per Share	54.78
EBITDA (p.s.)	10.68
Qtrly Earnings Growth	0 %
Operating Cash Flow	190 (M)
Levered Free Cash Flow	98 (M)

PE Ratio	22.65
PEG Ratio	2.4
Price to Book value	1.82
Price to Sales	1.66
Price to Cash Flow	16.35

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.